Ivonescimab Plus Chemotherapy Offers Promising Global Outcomes in Cancer Trials Latest findings from the HARMONi clinical trial confirm that ivonescimab plus chemotherapy effectively enhances overall survival rates in patients globally.

Ivonescimab Plus Chemotherapy Offers Promising Global Outcomes in Cancer Trials #Hong_Kong #Ivonescimab #Chemotherapy #HARMONi_Trial